Refractory hypocalcaemia-induced laryngeal spasm requiring emergency intubation in a malnourished young woman: overcoming diagnostic and therapeutic barriers in resource-limited settings Authors: Ayto A Negash, Mehreteab T Woudineh, Yitayew E Mohammed, Eyob Z Chafamo, Solomon Y Tilahun, Petros T Mekuria, Tekiy M Bedore, Ashagre E Hundeto Published: 2026 ABSTRACT AbstractBackgroundHypocalcaemia-induced laryngospasm is a rare but life-threatening cause of upper airway obstruction. Management is particularly challenging in resource-limited settings due to delayed laboratory results, limited monitoring, and unavailability of preferred medications.Case presentationA 20-year-old previously healthy woman presented with severe stridor, respiratory distress, and carpopedal spasm. Laboratory findings (obtained after initial treatment) revealed ionized calcium 0.9 mmol/L (reference range: 1.12–1.32 mmol/L), magnesium 1.6 mg/dL (reference range: 1.7–2.3 mg/dL), and severe vitamin D deficiency (25-hydroxyvitamin D 11.83 ng/mL; severe deficiency < 10–12 ng/mL). Despite aggressive intravenous calcium gluconate boluses (2 g × 4 additional doses after initial), continuous infusion (up to 2 mg/kg/h), and magnesium replacement, laryngospasm progressed to complete airway obstruction with desaturation to 70%. Emergency rapid sequence intubation was performed with ketamine 100 mg (2.5 mg/kg) and vecuronium 4 mg. Because calcitriol was unavailable, intramuscular cholecalciferol 50,000 IU was administered as off-label loading. The patient was extubated after 72 hours and discharged after 8 days with normalized levels on continued cholecalciferol therapy.ConclusionsFavourable outcomes can be achieved in resource-limited emergency departments through clinically guided aggressive therapy, timely airway intervention, and pragmatic use of available long-acting vitamin D when preferred agents are inaccessible. This underscores the value of adaptable strategies in low-resource settings.Keywords: Hypocalcaemia, Laryngeal spasm, Upper airway obstruction, Vitamin D deficiency, Resource-limited setting, Emergency intubation, Cholecalciferol Introduction Hypocalcaemia is a potentially life-threatening metabolic disorder that increases neuromuscular excitability, manifesting as perioral numbness, carpopedal spasm, tetany, and, in severe cases, laryngospasm leading to acute upper airway obstruction and respiratory failure [1, 2]. Severe hypocalcaemia is defined as ionized calcium < 1.0 mmol/L (normal range approximately 1.12–1.32 mmol/L) whereas refractory hypocalcaemia is defined as persistent symptomatic hypocalcaemia despite adequate IV calcium and magnesium correction. Laryngospasm due to hypocalcaemia is rare in adults; most reported cases resolve with intravenous calcium alone, and presentations requiring emergency intubation are exceptionally uncommon [3–6]. Documented adult cases from resource-limited settings in sub-Saharan Africa are virtually absent, where diagnostic tools and active vitamin D analogues are frequently unavailable [7]. Standard management of severe symptomatic hypocalcaemia begins with an intravenous calcium bolus (1–2 g calcium gluconate or chloride over 5–10 min) followed by a continuous infusion (0.5–2 mg/kg/h), titrated to clinical response and serial levels, with close ECG monitoring to prevent arrhythmias [8]. Concurrent hypomagnesaemia must be corrected, as magnesium is a cofactor for parathyroid hormone (PTH) secretion and action; low magnesium impairs PTH release and causes end-organ resistance, rendering hypocalcaemia refractory until magnesium is repleted [6, 9, 10]. Vitamin D deficiency (severe when 25-hydroxyvitamin D < 10–12 ng/mL) frequently coexists and exacerbates the condition, particularly in malnourished patients. In resource-limited environments, ionized calcium assays, PTH measurement, and calcitriol are often unavailable, forcing reliance on clinical signs and locally available agents [9, 11, 12]. We report a case of refractory hypocalcaemia-induced laryngospasm causing upper airway obstruction, which required emergency intubation in a malnourished young woman at a resource-limited Ethiopian emergency department. This case demonstrates how timely airway management and pragmatic adaptation, using off-label intramuscular cholecalciferol when calcitriol was unavailable, enabled successful stabilization. Case presentation A 20-year-old previously healthy Ethiopian female presented to the emergency department with a 1-day history of persistent, spontaneous muscle twitching in her hands and feet, associated with tingling sensations. She also experienced difficulty breathing and a high-pitched sound on inhalation with increasing shortness of breath. There was no prior history of thyroid, parathyroid, or renal disease, no medication use, and no family history of endocrine disorders. On assessment, vital signs showed pulse rate 110 bpm, blood pressure 110/60 mmHg, respiratory rate 30–35 breaths per minute, and oxygen saturation 88% on room air. She appeared acutely ill and emaciated with marked suprasternal, intercostal, and subcostal retractions, severe continuous stridor, and carpopedal spasms. Mid-upper arm circumference (MUAC) was 18 cm, indicating severe malnutrition. Neck and chest examination revealed no goitre, lymphadenopathy, masses, or tenderness. Other systems were unremarkable. Initial laboratory results (drawn after the first calcium bolus and 1 h of continuous infusion, received 6 h later from a private facility 200 km away) showed ionized calcium 0.9 mmol/L (normal 1.12–1.32 mmol/L), magnesium 1.6 mg/dL (normal 1.7–2.3 mg/dL), TSH 0.336 µIU/mL and repeated TSH 1.55 µIU/mL (normal 0.35–4.94 µIU/mL), total calcium 8.5 mg/dL (normal 8.4–10.2 mg/dL), and 25-hydroxyvitamin D 11.83 ng/mL (severe deficiency < 10–12 ng/mL). CBC, renal function, liver function, and other electrolytes were normal. Further workup (Phosphorus, PTH, free T3/T4, thyroid antibodies) was impossible due to financial constraints and unavailability. Ionized calcium testing was unavailable locally. Because frequent monitoring was not feasible, management was guided primarily by clinical signs (Table 1). Table 1Consolidated laboratory resultsParameterDay 0Day 4Day 7Day 14UnitReference RangeWhite Blood Cell (WBC)87——×10³/µL2.90–20.00Neutrophils6454——%15–72Haemoglobin (HGB)14.313.6——g/dL10–21Haematocrit (HCT)3738.8——%30–64MCV8178——fL71–125Platelets (PLT)136146——×10³/µL140–470High-sensitivity Thyroid Stimulating Hormone (HsTSH) 0.336 1.55——µIU/mL0.35–4.94 (lab) / 0.27–4.2 (standard adult)Total Calcium8.59.59.29.4mg/dL8.4–10.2 (lab) / 8.5–10.2 (standard)Corrected calcium9.116——mg/dL8.4–10.2 (lab) / 8.5–10.2 (standard)Ionized Calcium 0.90 1.121.141.21mmol/L1.12–1.32 (lab) / 1.05–1.3 (standard)Magnesium 1.6 2.11.92.2mg/dL1.7–2.3Sodium (Na⁺)136149——mmol/L135–151Potassium (K⁺)4.43.8——mmol/L3.5–5.1Creatinine0.52———mg/dL0.0–1.3Urea21.8———mg/dL12.8–42.8Albumin3.23–———g/dL3.5–5.2AST / ALT31/0.37———U/L0–41 Vitamin D 11.83 — 24 33ng/mL< 10–12 = severe deficiency; <20 = deficiency; 30 + = sufficient Urinalysis Normal————NegativeNote: Laboratory values on Day 0 were obtained after the initial calcium bolus and 1 hour of continuous infusion. RedBold values indicate abnormal results. Dashes (—) indicate test not repeated on that day Consolidated laboratory results Note: Laboratory values on Day 0 were obtained after the initial calcium bolus and 1 hour of continuous infusion. RedBold values indicate abnormal results. Dashes (—) indicate test not repeated on that day The only available ECG machine malfunctioned, so continuous cardiac monitoring was used as an alternative, which showed normal results. A bedside neck ultrasound was also performed and revealed normal findings. Refractory hypocalcaemia was defined as persistent symptomatic hypocalcaemia (e.g., ongoing laryngospasm and respiratory distress) despite adequate intravenous calcium replacement and concurrent magnesium correction. Management was initiated at presentation (time 0) with a 2 g intravenous calcium gluconate bolus, followed by a continuous infusion at 1.5 mg/kg/h (patient weight 40 kg), and 3 L/min intranasal oxygen. Initially, there was transient improvement, but airway distress persisted. At 1 h, the stridor worsened, and the oxygen requirement increased to 4 L/min. In response, the calcium infusion rate was escalated to 2 mg/kg/h, and a 2 g magnesium sulfate bolus was administered. At 2 h, a third episode of airway distress occurred, prompting a second 2 g calcium gluconate bolus. By 4 h, there was further deterioration with increasing respiratory distress, leading to a third 2 g calcium gluconate bolus and a second 2 g magnesium sulfate bolus. At 6 h, a fifth episode of airway compromise, accompanied by worsening stridor, resulted in a fourth 2 g calcium gluconate bolus, while the calcium infusion rate was maintained at 2 mg/kg/h. By 8 h, critical deterioration occurred with SpO₂ dropping to 70% despite high-flow oxygen via a non-rebreather mask. Rapid sequence intubation was performed using ketamine 100 mg (2.5 mg/kg) and vecuronium 4 mg IV, with vecuronium chosen for its longer duration of action to prevent recurrent laryngospasm. Intubation was successful on the first attempt. Immediately after intubation, 50,000 IU intramuscular cholecalciferol was administered as a loading dose (calcitriol unavailable). The patient was transferred to the ICU on mechanical ventilation with continued calcium infusion. She showed progressive improvement and was successfully extubated after 72 hours. She was discharged from the hospital after 8 days. At follow-up, ionized calcium and vitamin D levels had normalised. Cholecalciferol supplementation was initially given weekly and later changed to every 4 weeks for long-term maintenance. Discussion Severe hypocalcaemia-induced laryngospasm remains a rare but life-threatening emergency in adults [3–5, 13]. Most reported cases resolve with intravenous calcium replacement alone, yet progression to complete upper airway obstruction requiring emergency intubation is exceptional, particularly in resource-limited settings where such presentations are rarely documented [7, 14]. In this patient, profound neuromuscular irritability from an ionized calcium level of 0.9 mmol/L was compounded by severe vitamin D deficiency (25-hydroxyvitamin D 11.83 ng/mL; severe deficiency defined as < 10–12 ng/mL) and concurrent hypomagnesaemia (1.6 mg/dL). Vitamin D deficiency is a common and important underlying cause of refractory hypocalcaemia, as it reduces intestinal calcium absorption and impairs PTH action, particularly in malnourished individuals [9, 10, 12, 15]. Hypomagnesaemia further exacerbates the refractoriness by impairing parathyroid hormone secretion and inducing end-organ resistance; magnesium repletion is therefore essential before calcium homeostasis can be restored [11, 16]. Management occurred in a resource-limited emergency department characterised by delayed laboratory results, unavailability of ionized calcium testing and calcitriol, and malfunction of the only ECG machine. Treatment relied on clinical response with aggressive calcium and magnesium replacement, followed by rapid sequence intubation when desaturation occurred despite high-flow oxygen. Off-label intramuscular cholecalciferol (50,000 IU loading dose) was used immediately after intubation because the preferred short-acting active vitamin D analogue was unavailable. This agent supported both acute stabilisation and long-term calcium homeostasis. Vitamin D deficiency is highly prevalent in sub-Saharan Africa, including Ethiopia, where it affects a large proportion of the population due to malnutrition and socioeconomic factors [15]. In such settings, the combination of diagnostic constraints and limited access to essential medications makes management of severe metabolic emergencies particularly challenging [17]. Timely airway intervention served as a critical bridge, while pragmatic use of locally available medications compensated for the absence of ideal resources. Airway management in resource-limited emergency and ICU settings further requires rapid clinical decision-making when advanced monitoring is unavailable [18]. The successful extubation after 72 h and discharge after 8 days with normalised ionized calcium demonstrate that good patient outcomes remain possible through high clinical suspicion, response-guided therapy, and context-appropriate adaptations when guideline-recommended agents and recommended monitoring are inaccessible [19–22]. Limitations Limitations inherent to this resource-limited setting include delayed laboratory results (ionized calcium, magnesium, and vitamin D received 6 h later), unavailability of PTH and thyroid antibody testing, and malfunction of the only ECG machine, forcing reliance on clinical signs. These constraints reflect everyday realities in many low-resource emergency departments and highlight the value of pragmatic, patient-centred adaptations. Conclusion In resource-limited emergency departments, refractory hypocalcaemia-induced laryngeal spasm can be successfully managed despite significant diagnostic, therapeutic, and monitoring limitations. Aggressive response-guided therapy combined with timely emergency intubation and pragmatic off-label use of long-acting cholecalciferol enabled full recovery. This case illustrates that good patient outcomes are possible in challenging low-resource settings through clinical judgment and adaptable use of locally available agents when ideal resources are absent. Such pragmatic approaches are critical for strengthening emergency care capacity and reducing mortality from treatable metabolic emergencies in low-resource settings. Acknowledgements We thank the clinical team and the patient for consent. Biographies Dr. Ayto A. Negash Dr. Negash is an Assistant Professor of Emergency Medicine and Critical Care and an MPH candidate. He is affiliated with Werabe and University and Wachemo University, Ethiopia. His research interests include Emergency Medicine, Critical Care, and public health. Dr. Mehreteab T. Woudineh MD, pediatrician Dr. Yitayew E. Mohammed MD, Assistant Professor of Internal Medicine Dr. Eyob Z. Chafamo MD, General Practitioner Dr. Solomon Y. Tilahun MD, General Practitioner Petros T. Mekuria MD, Assistant Professor of Neurosurgery Dr. Tekiy M. Bedore MD, Assistant Professor of Emergency Medicine and Critical Care Dr. Ashagre E. Hundeto MD, General Practitioner Author contributions A.A.N.: A correspondent Author Involved in patient management, conceptualized the case report, drafted the manuscript, reviewed the clinical data, and approved the final version. M.T.W., Y.E.M, E.Z.C, S.Z.T, P.T.M, T.M.B, and A.E.H. contributed to clinical data collection, literature review, and manuscript editing. All authors reviewed and approved for publication. Funding There is no source of funding for this manuscript. Data availability Available from corresponding author on reasonable request. Declarations Ethics approval and consent to participate Not required for single case report per institutional policy. Consent for publication Written informed consent obtained from the patient. Duplicate publication This manuscript is original. AI statement No AI tools were used in its preparation. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Available from corresponding author on reasonable request.